Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 61 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/4/2007 First Published: 10/24/2006


1.		Phase II/III Study of Neoadjuvant Therapy Comprising Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) (Abraxane®) in Women With Previously Untreated, Unresected, Stage II-IIIB Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Other				WHC-MRI-GU-2006-097 NCT00397761


2.		Patients With Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				CA031 NCT00540514


3.		A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				Other				INST 0553C NCT00659269


4.		Gemcitabine (GEMZAR) Plus ABI-007 (ABRAXANE)In Patients With Advanced Metastatic Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				CA040 NCT00398086


5.		Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Over 18				Other				DOXIL NCT00442260

Last Modified: 6/13/2008 First Published: 5/1/2007


6.		Phase I/II Study of Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Pemetrexed Disodium in Patients With Advanced Non-Small Cell Lung Cancer, Breast Cancer, or Other Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				UCD-185 UCD 185, UCD-200614714, NCT00470548

Last Modified: 8/20/2008 First Published: 10/11/2007


7.		Phase I/II Study of Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Carboplatin, and Concurrent Radiotherapy Followed by Consolidation Chemotherapy Comprising Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				VU-VICC-THO-0746 VICC-THO-0746, NCT00544648


8.		Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				07-069 NCT00570674


9.		Phase I & II Trial of Intravesicular Abraxane for Treatment-Refractory Bladder Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Over 18				Other				AAAC1114 NCT00583349


10.		A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				19 and over				Other, Pharmaceutical / Industry				VAST-B NCT00748553

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute